Abstract
Hemolytic disease of the newborn (HDN) can occur when there are fetomaternal incompatibilities within any number of different erythrocyte antigen systems, including the RhD, Cc, Ee, Kidd and Duffy, and Kell antigen systems. In these disorders, maternal antibodies are developed by alloimmunization of the mother to fetal red blood cells during pregnancy when the fetal cells carry an alloantigen inherited from the father. The maternal antibodies result in the destruction of fetal erythrocytes leading to severe hemolytic anemia and hyperbilirubinemia. Permanent neurologic damage can result from HDN, and in extreme cases loss of the fetus or death of the neonate may occur. In subsequent pregnancies, it is important to determine the status of the incompatible allele in the fetus. If the father is heterozygous or homozygous for the allele, the chance of the fetus inheriting the paternal alloallele to which the mother is immunologically sensitized is 50 or 100%, respectively. Fetuses that do not inherit the alloallele will not be at risk for HDN.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liley, A. W. (1961) Liquor amnii analysis in management of pregnancy complicated by rhesus immunization. Am. J. Obstet. Gynecol. 82, 1359–1371.
Bowman, J. M. and Pollock, J. M. (1985) Transplacental fetal hemorrhage after amniocentesis. Obstet. Gynecol. 66, 749–754.
Cherif-Zahar, B., Mattei, M. G., Le Van Kim, C., Bailly, P., Cartron, J. P., and Colin, Y. (1991) Localization of the human Rh blood group gene structure to chromosome region 1p34.3-1p36.1 by in situ hybridization. Hum. Genet. 86, 398–400.
Colin, Y., Cherif-Zahar, B., Le Van Kim, C., Taynal, V., Cherrier, C., and Cartron, J. P. (1991) Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 78, 2747–2752.
Cherif-Zahar, B., Bloy, C., Le Van Kim, C., Blanchar, D., Bailly, P., Hermand, P., Salmon, C., Cartron, J. P., and Colin, Y. (1990) Molecular cloning and primary structure of a human blood group Rh polypeptide. Proc. Natl. Acad. Sci. USA 87, 6243–6247.
Le Van Kim, C., Mouro, I., Cherif-Zahar, B., Raynal, V., Cherrier, C., Cartron, J. P., Colin, Y. (1992) Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc. Natl. Acad. Sci. USA 89, 10,925–10,929.
Arce, M. A., Thomson, E. S., Wagner, S., Coyne, K. E., Ferdman, B. A., and Lublin, D. M. (1993) Molecular cloning of RhD cDNA derived from a gene in RhD positive, but not RhD-negative individuals. Blood 82, 651–655.
Mouro, I., Colin, Y., Cherif-Zahar, B., Cartron, J. P., and Le Van Kim, C. (1993) Molecular genetic basis of the human Rhesus blood group system. Nat. Genet. 5, 62–65.
Beckers, E. A. M., Faas, B. H. W., Simsek, S, Overbeeke, M. A. M., van Rhenen, D. J., Wallace, M., von dem Borne, A. E., and van der Schoot, C. E. (1996) The genetic basis of a new partial D antigen: DDBT. Br. J. Haematol. 93, 720–727.
Bennett, P. R., Le Van Kim, C., Colin, Y., Warwick, R. M., Charif-Zahar, B., Fisk, N. M., and Cartron, J. P. (1993) Prenatal determination of RhD type by DNA amplification. N. Engl. J. Med. 329, 607–610.
Wolter, L. C., Hyland, C. A., and Saul, A. (1993) Rhesus D genotyping using the polymerase chain reaction. Blood 85, 1682.
Simsek, S., Faas, R. H. W., Bleeker, P. M. M, Overbeeke, M. A. M., Cuijpers, H. T. M., van der Schoot, C. E., and von dem Borne, A. E. (1995) Rapid RhD genotyping by polymerase chain reaction-based amplification of DNA. Blood 85, 2975–2980.
Mouro, I., Le Van Kim, C., Rouillac, C., van Rhenen, D. J., Le Pennec, P. Y., Bailly, P., Cartron, J. P., and Colin, Y. (1994) Rearrangements of the blood group RhD gene associated with the D(VI) category phenotype. Blood 83, 1129–1135.
Okuda, H., Kawano, M., Iwamoto, S., Tanaka, M., Seno, T., Okubo, Y., and Kajii, E. (1997) The RHD gene is highly detectable in RhD-negative Japanese donors. J. Clin. Invest. 100, 373–379.
Aubin, J.-T., Le Van Kim, C., Mouro, I., Colin, Y., Bignozzi, C., Brossard, Y., and Cartron, J.-P. (1997) Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br. J. Haematol. 98, 356–364.
Hessner, M. J., Agostini, T. A., Bellissimo, D. B., Endean, D. J., Pircon, R. A., and Kirschbaum, N. E. (1997) The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders. Am. J. Obstet. Gynecol. 176, 327–333.
Denomme, G. A., Waye, J., Burrows, R. F., Hayward, C. P. M., Warkentin, T. E., Horsewood, P., Smith, J. W., Jelsema, R. D., Zuidema, L. J., and Kelton, J. G. (1995) The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis. Br. J. Haematol. 91, 742–746.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Hessner, M.J., Bellissimo, D.B. (2001). Prenatal Genotyping of the RhD Locus to Identify Fetuses at Risk for Hemolytic Disease of the Newborn. In: Killeen, A.A. (eds) Molecular Pathology Protocols. Methods in Molecular Medicine™, vol 49. Humana Press. https://doi.org/10.1385/1-59259-081-0:427
Download citation
DOI: https://doi.org/10.1385/1-59259-081-0:427
Publisher Name: Humana Press
Print ISBN: 978-0-89603-681-9
Online ISBN: 978-1-59259-081-0
eBook Packages: Springer Protocols